| Press Release - | Minimally Invasive Surgery Market to Reach USD 432.3 Million by 2035 |
Vantage Market Research | 29 Jan 2025
Healthcare
Minimally Invasive Surgery Market to Reach USD 432.3 Million by 2035

According to analysts at Vantage Market Research, the Global Minimally invasive surgery Market size is worth USD 78.5 Billion in 2024 and is projected to reach USD 432.3 Billion by 2035, growing at a CAGR (Compound Annual Growth Rate) of 16.8% from 2024 to 2035. Key trends of market include rise of robotic-assisted surgeries, advancements in imaging technologies, growing preference for outpatient procedures, and development of smaller surgical instruments.
Laparoscopic procedures are less invasive and offer cost savings in terms of pre- and post-operative care, as well as shorter hospital stays. These surgeries result in reduced blood loss, fewer complications after surgery, and quicker recovery times for patients. Furthermore, health insurance providers in some countries are increasingly covering minimally invasive surgeries. Physicians prefer these procedures over traditional open surgeries due to their cost-saving potential for hospitals.
Emerging markets present significant growth opportunities for minimally invasive surgery market. Factors such as lower regulatory barriers, improvements in healthcare infrastructure, expanding patient populations, rising healthcare spending, increasing disposable incomes, and a growing aging demographic are driving this growth. The Asia Pacific region, in particular, offers a more adaptable and business-friendly environment compared to developed countries. This, combined with increasing competition in mature markets, is prompting leading players in the minimally invasive surgery market to focus on emerging countries.
Arthrex Launches TheNanoExperience.com to Highlight Nano Arthroscopy Benefits
Our market research reports provide comprehensive insights that are essential for strategic decision-making. We cover all key aspects of the market, including dynamics such as drivers, restraints, opportunities, and challenges, alongside the latest industry trends. Our analysis includes an in-depth technology roadmap, product life cycle evaluation, and PESTLE analysis, ensuring a thorough understanding of the market environment. We also assess GDP growth outlooks, examine regional market landscapes, and evaluate the impact of major events like the COVID-19 pandemic. Additionally, our reports feature a detailed competitive landscape, including company market shares and profiles, providing actionable intelligence to empower your business strategies.
Medtronic Secures CE Mark Approval for Affera Mapping and Ablation System
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Healthcare
Minimally Invasive Surgery Market to Reach USD 432.3 Million by 2035
29 Jan 2025
Min Read
Access Full Report
Minimally Invasive Surgery Market to Reach USD 432.3 Million by 2035
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Latest Press Release
Contact
Toll Free Number+1 (877) 462-2282